Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Expert Opinion on Pharmacotherapy|May 7, 2019
Evaluating ADS5102 (amantadine) for the treatment of Parkinson's disease patients with dyskinesiaThomas Müller, Wilfried Kuhn, Jan-Dominique Möhr
Neuroscience Letters|April 17, 2003
Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's diseaseThomas Müller, Thomas Büttner, Ali Farshad Gholipour, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 20, 2010
No increased chromosomal damage in L-DOPA-treated patients with Parkinson's disease: a pilot studyRajaraman Gnana Oli, Gholamreza Fazeli, Wilfried Kuhn, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 23, 2002
Towards a high resolution separation of human cerebrospinal fluidAlbert Sickmann, Wilma Dormeyer, Stefanie Wortelkamp, et al.
Journal of Neurology|May 12, 2011
Basic science in Parkinson's disease: its impact on clinical practiceJörg B Schulz, Manfred Gerlach, Gabriele Gille, et al.
Psychopharmacology|November 6, 2002
Effects of acute psychological stress on adhesion molecules, interleukins and sex hormones: implications for coronary heart diseaseAndreas Heinz, Derik Hermann, Michael N Smolka, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2004
Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HDJürgen Andrich, Carsten Saft, Anneliese Arz, et al.
Journal of Neurology|September 20, 2008
Lewy body dementia and Parkinson's disease with dementiaRichard Dodel, Ilona Csoti, Georg Ebersbach, et al.
Pageof 3